Foreign Scientists Steer Away from States

D.F. Dowd When terrorists unleashed a new kind of fear in the United States on Sept. 11, 2001, few Americans may have guessed their attacks would also have significant repercussions for scientists and scientific research. Frustration over visa delays, discouragement over visa denials, and fears that US students, researchers, and employers might now be reluctant to work with them have led some foreign scholars to look elsewhere to advance their careers. As a result, concerns are growing that ne

Written byDana Wilkie
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

When terrorists unleashed a new kind of fear in the United States on Sept. 11, 2001, few Americans may have guessed their attacks would also have significant repercussions for scientists and scientific research. Frustration over visa delays, discouragement over visa denials, and fears that US students, researchers, and employers might now be reluctant to work with them have led some foreign scholars to look elsewhere to advance their careers. As a result, concerns are growing that new immigration policies could--or already have--put foreign students at such a competitive disadvantage that their failure to come to this country will put the United States at a disadvantage as well.

"In the long run, the progression of our research is at stake," says Debbie Fountain, with the National Cancer Institute's Office of Management. "These folks play a major part in our research team here in Bethesda, and the longer it takes to bring ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies